Lung deposition of nebulized surfactant in newborn piglets: Nasal CPAP vs Nasal IPPV
Autor: | Federico Bianco, Doris Cunha-Goncalves, Valeria Perez-de-Sa, Anders Nord, Xabi Murgia, Martin Schlun, Francesca Ricci, Rikard Linner, Fabrizio Salomone |
---|---|
Rok vydání: | 2019 |
Předmět: |
Pulmonary and Respiratory Medicine
Neonatal respiratory distress syndrome Swine medicine.medical_treatment Context (language use) Infant Premature Diseases Nose Pulmonary function testing Intermittent Positive-Pressure Ventilation 03 medical and health sciences Surface-Active Agents 0302 clinical medicine 030225 pediatrics medicine Animals Continuous positive airway pressure Respiratory system Lung Positive end-expiratory pressure Phospholipids Mechanical ventilation Biological Products Respiratory Distress Syndrome Newborn Continuous Positive Airway Pressure business.industry Nebulizers and Vaporizers Pulmonary Surfactants medicine.disease Respiration Artificial 030228 respiratory system Animals Newborn Anesthesia Pediatrics Perinatology and Child Health business Respiratory minute volume Infant Premature |
Zdroj: | Pediatric pulmonologyREFERENCES. 55(2) |
ISSN: | 1099-0496 |
Popis: | Background: Nasal continuous positive airway pressure support (nCPAP) is the standard of care for prematurely born infants at risk of neonatal respiratory distress syndrome (nRDS). However, nasal intermittent positive pressure ventilation (NIPPV) may be an alternative to nCPAP in babies requiring surfactant, and in conjunction with surfactant nebulization, it could theoretically reduce the need for invasive mechanical ventilation. We compared lung deposition of nebulized poractant in newborn piglets supported by nCPAP or NIPPV. Methods: Twenty-five sedated newborn piglets (1.2-2.2 kg) received either nCPAP (3 cmH2O, n = 12) or NIPPV (3 cmH2O positive end expiratory pressure+3 cmH2O inspiratory pressure, n = 13) via custom-made nasal prongs (FiO2 0.4, Servo-i ventilator). Piglets received 200 mg kg−1 of technetium-99m-surfactant mixture continuously nebulized with a customized eFlow-Neos investigational vibrating-membrane nebulizer system. Blood gases were taken immediately before, during, and after nebulization. The deposition was estimated by gamma scintigraphy. Results: Mean surfactant deposition in the lungs was 15.9 ± 11.9% [8.3, 23.5] (mean ± SD [95% CI]) in the nCPAP group and 21.6 ± 10% [15.6, 27.6] in the NIPPV group (P =.20). Respiratory rates were similar in both groups. Minute volume was 489 ± 203 [360, 617] in the nCPAP group and 780 ± 239 [636, 924] mL kg−1 min−1 in the NIPPV group (P =.009). Blood gases were comparable in both groups. Conclusion: Irrespective of the noninvasive ventilatory support mode used, relatively high lung deposition rates of surfactant were achieved with nebulization. The amounts of deposited surfactant might suffice to elicit a pulmonary function improvement in the context of nRDS. (Less) |
Databáze: | OpenAIRE |
Externí odkaz: |